SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-016275
Filing Date
2021-11-22
Accepted
2021-11-22 16:30:34
Documents
15
Period of Report
2021-11-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hrmy-20211118x8k.htm   iXBRL 8-K 45999
2 EX-99.1 hrmy-20211118xex99d1.htm EX-99.1 8597
3 GRAPHIC hrmy-20211118x8k001.jpg GRAPHIC 1227
4 GRAPHIC hrmy-20211118xex99d1001.jpg GRAPHIC 7883
  Complete submission text file 0001558370-21-016275.txt   195148

Data Files

Seq Description Document Type Size
5 EX-101.SCH hrmy-20211118.xsd EX-101.SCH 3066
6 EX-101.LAB hrmy-20211118_lab.xml EX-101.LAB 16070
7 EX-101.PRE hrmy-20211118_pre.xml EX-101.PRE 10229
8 EXTRACTED XBRL INSTANCE DOCUMENT hrmy-20211118x8k_htm.xml XML 4937
Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Filer) CIK: 0001802665 (see all company filings)

IRS No.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39450 | Film No.: 211432918
SIC: 2834 Pharmaceutical Preparations